Named Patient Medicines

Before preparing the infusion, read the instructions carefully. Infusions should not be mixed with other medicinal products or intravenous solutions. After the infusion is finished, it is important to flush the IV with sodium chloride 9 mg/ml (0.9%) injection solution to avoid adverse reactions. If there are adverse reactions, reduce the infusion rate. Unused product should be disposed of according to local regulations. Benefits of ARZERRA OFATUMUMAB INJECTION 1000MG 50 The benefits of Arzerra Ofatumumab Injection 1000MG 50ML are numerous, but there are also some risks associated with it. For example, ARZERRA can cause serious infusion reactions, including bronchospasm, dyspnea, and upper respiratory tract infection. If you experience these reactions, you should discontinue the treatment immediately. Arzerra Ofatumumab Injection is an approved drug for patients with CLL who have not responded to previous treatments. It is used in combination with another drug, called chlorambucil (Leuk...

If you've been prescribed XELJANZ tofacitiminib for your liver condition, you should understand that it may affect your liver enzymes. If you're taking another medicine that affects these enzymes, you should talk to your healthcare provider. If you have the Hepatitis B or C virus, you should tell your healthcare provider before starting treatment with XELJANZ tofacitinib. This medication can affect your blood and liver, so your doctor may do blood tests to make sure your liver is functioning properly. XELJANZ tofacitinib XELJANZ tofacinib is supplied as tablets in the dosage form of 5 mg to 8 mg. These tablets contain tofacitinib as the active ingredient and are coated with croscarmellose sodium and HPMC 2910/Hypromellose 6cP. They also contain magnesium stearate, titanium dioxide, and triacetin. The recommended daily dose is 5 mg twice a day. XELJANZ is approved for the treatment of moderate-to-severe ulcerative colitis in adults. It is also approved for the treatment of activ...

  WHAT IS IDHIFA (Enasidenib)? IDHIFA Medicine IDHIFA is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children. IDHIFA may cause serious side effects, including: Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells which may be life-threatening or lead to death if not treated. Differentiation syndrome has happened within 1 day and up to 5 months after starting IDHIFA. Check the following symptoms below. ·          fever ·          cough ·          shortness of breath ·          swelling of arms and legs ·         ...

  In a clinical trial, half of patients with metastatic colon or rectal cancer treated with LONSURF® (trifluridine and tipiracil) Tablets were still alive at 7.1 months and half of patients who received placebo were still alive at 5.3 months were alive. Worsening of disease or death occurred in 88% of patients treated with LONSURF and 94% of patients receiving placebo. In the clinical trial, half of the patients with metastatic colon cancer treated with LONSURF were still alive at 5.7 months and half of the patients who received placebo were still alive at 3.6 months. Worsening of disease or death occurred in 85% of patients treated with LONSURF and 92% of patients receiving placebo.   Signs and Important Safety Information LONSURF is a prescription medicine used to treat adults • Colorectal cancer that has spread to other parts of the body and has been previously treated or cannot receive certain chemotherapy drugs. • A type of stomach cancer called gastric cancer, in...

 Type 2 diabetes is a disease in which your body does not produce enough of a hormone called insulin or does not use insulin as it should. So when there is a problem with insulin, glucose builds up in your blood. You probably have this called high blood sugar. The other two main types are gestationalgia, in which your body stops making insulin, and gestationalgia, which occurs in pregnant women. You may not even know you have type 2 diabetes until it affects your health. About 1 in 4 people with the condition do not know they have the disease. Symptoms of Type 2 Diabetes • Excessive thirst. When sugar builds up in your blood, your kidneys work longer to get rid of it. This draws fluid out of your tissues and makes you dehydrated, making you feel thirsty. • More hunger. Since diabetes can block glucose from getting into your cells, you still feel hungry after eating. • Frequent urination. You will urinate more because your kidneys are working to get rid of the extra sugar in y...

What is Glyxambi? Glyxambi (empagliflozin and linagliptin) is a combination of an inhibitor of the sodium-glucose co-transporter (SGLT2) and an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme as an adjunct to diet and exercise to improve glycemic control. What are the side effects of Glyxambi? Common side effects of Glyxambi include: • urinary tract infection • Common cold symptoms • Upper respiratory tract infection • Genital Yeast Infection • Increased urination • Joint pain • Nausea • runny or stuffy nose • Diarrhea • cough • Elevated blood cholesterol or fat • Diarrhea Glyxambi Dosage The recommended dose of Glyxambi is 10 mg empagliflozin/5 mg linagliptin, taken once daily in the morning, with or without food. In patients who tolerate Glyxambi, the dose may be increased to 25 mg empagliflozin/5 mg linagliptin once daily. Do drugs, substances, or supplements interact with Glyxambi? Glyxambi during pregnancy and lactation During pregnancy...

What is Bydureon (exenatide)? Bydureon is a brand-name medicine used to improve blood sugar levels in people with type 2 diabetes. It comes as a liquid suspension to be given by injection under the skin (subcutaneously). Bydureon contains a medicine called extended-release exenatide. Bydureon vs Bydureon BCise Bydureon BCise is another form of Bydureon. It contains the same medicine (extended-release exenatide). Bydureon and Bydureon BCise work in the same way and have very similar effects in the body. You push the autoinjector against your skin, and it injects the medicine automatically. There are fewer steps required to inject Bydureon using this autoinjector than using a syringe or pen injector. This can make Bydureon BCise easier to use than Bydureon. In clinical studies, Bydureon reduced hemoglobin A1c (HbA1c) by approximately 0.88 to 1.6 percent after 24 to 28 weeks of treatment. In the Bydureon BCise study, HbA1c was reduced by approximately 1.07 to 1.39 percent after ...